A Clinical Study of TQH2929 in Healthy Adult Subjects
Clinical trial NCT06156280 · COMPLETED
Trial details
- NCT number
- NCT06156280
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2024-08-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.